ClinConnect ClinConnect Logo
Search / Trial NCT04505020

The Innovation of 3D Printing for Preoperative Planning in Hip Preservation Surgery

Launched by NOVA SCOTIA HEALTH AUTHORITY · Aug 6, 2020

Trial Information

Current as of July 09, 2025

Enrolling by invitation

Keywords

Femoroacetabular Impingement Cam Lesion 3 D Printing Pre Operative Planning

ClinConnect Summary

In this study, we investigate the use of 3D models during pre and intra-operative planning could improve the success of hip arthroscopy and reduce the incidence of revision cases. By adding an adjunct to the common suite of pre-operative imaging modalities (X-ray, MRI and CT), we can change the surgeon's understanding of each patient's individual morphology with a tactile physical model. This study will compare the success of hip arthroscopy in patients with or without 3D printed models (in addition to traditional pre-operative imaging).

This will be a single-center, blinded observer, rand...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Radiological proven diagnosis of cam-type femoroacetabular impingement (FAI)
  • Exclusion Criteria:
  • Patients with advanced arthritis (Tonnis Grade III or Kellgren-Lawrence Grade III or IV or evidence of less than 2 mm of joint space, as determined by conventional radiographs.)
  • Patients with 1cm2 (or greater) of cartilage delamination in the hip
  • Patients with type III or IV heterotopic ossification
  • Patients with avascular necrosis
  • Patients who are unable to provide informed consent
  • Patients who are undergoing revision hip arthroscopy
  • Patients who are pregnant
  • Patients who have the presence of local or systemic infection
  • Patients with an inability to cooperate with and/or comprehend post-operative instructions
  • Patients with nonvascular surgical sites (MRI proven)
  • Patients with cancer

About Nova Scotia Health Authority

The Nova Scotia Health Authority (NSHA) is a leading healthcare organization dedicated to enhancing the health and well-being of individuals and communities across Nova Scotia, Canada. As the largest provider of health services in the province, NSHA is committed to advancing clinical research and innovation through rigorous clinical trials that aim to improve patient care and outcomes. With a focus on collaboration, NSHA engages healthcare professionals, researchers, and patients to address pressing health challenges and contribute to the global body of medical knowledge. By fostering a culture of evidence-based practice and continual improvement, NSHA plays a pivotal role in shaping the future of healthcare delivery in the region.

Locations

Halifax, Nova Scotia, Canada

Patients applied

0 patients applied

Trial Officials

Ivan Wong, Dr.

Principal Investigator

Nova Scotia Health Authority

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials